Log In
BCIQ
Print this Print this
 

Fareston, toremifene citrate (formerly Acapodene)

  Manage Alerts
Collapse Summary General Information
Company Orion Corp.
DescriptionNon-steroidal selective estrogen receptor modulator (SERM)
Molecular Target Estrogen receptor (ESR1)
Mechanism of ActionSelective estrogen receptor modulator (SERM)
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationBreast cancer
Indication DetailsTreat breast cancer in postmenopausal women
Regulatory Designation
PartnerEisai Co. Ltd.;
Kyowa Hakko Kirin Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/25/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today